Works by Heise, Tim

Results: 128

Pains and needs of patients with type 2 diabetes as targets for novel technologies.

Published in:

Clinical Diabetology, 2020, v. 9, n. 6, p. 400, doi. 10.5603/DK.2020.0052

By:

Gruchała, Aneta;
Cypryk, Katarzyna;
Schliess, Freimut;
Bobeff, Katarzyna;
Heise, Tim;
Gurdała, Mikołaj;
Szadkowska, Agnieszka;
Mianowska, Beata

Publication type:

Article

Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on C-peptide kinetics.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 1, p. 12, doi. 10.1002/cpdd.115

By:

Polidori, David;
Sha, Sue;
Heise, Tim;
Natarajan, Jaya;
Artis, Eunice;
Wang, Shean‐Sheng;
Vaccaro, Nicole;
Rothenberg, Paul;
Stirban, Alin

Publication type:

Article

Letter to the editor regarding: 'Pharmacokinetics of teneligliptin in subjects with renal impairment.' Halabi et al., Clinical Pharmacology in Drug Development 2013;2:246-254.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 5, p. 417, doi. 10.1002/cpdd.119

By:

Graefe‐Mody, Ulrike;
Friedrich, Christian;
von Eynatten, Maximilian;
Thiemann, Sandra;
Heise, Tim;
Woerle, Hans‐Juergen

Publication type:

Article

Biosimilar insulins: Narrative review of the regulatory framework and registration studies.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, p. 16, doi. 10.1111/dom.16320

By:

Heise, Tim;
DeVries, J. Hans

Publication type:

Article

Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 3, p. 1507, doi. 10.1111/dom.16159

By:

Mather, Kieren J.;
Mari, Andrea;
Weerakkody, Govinda;
Heise, Tim;
DeVries, J. Hans;
Urva, Shweta;
Coskun, Tamer;
Milicevic, Zvonko;
Haupt, Axel;
Thomas, Melissa K.

Publication type:

Article

Absence of a glucose‐lowering effect in glucose clamp procedures with a long‐acting insulin analogue.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 12, p. 6067, doi. 10.1111/dom.15939

By:

DeVries, J. Hans;
Heckermann, Sascha;
Heise, Tim

Publication type:

Article

Back Cover.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. C4, doi. 10.1111/dom.16055

By:

Andersen, Grit;
Eloy, Rosy;
Heise, Tim;
Gaudier, Martin;
Mégret, Claire;
Seroussi, Cyril;
Chan, You‐Ping;
Soula, Olivier;
Riddle, Matthew;
DeVries, J. Hans

Publication type:

Article

ADO09, a co‐formulation of pramlintide and insulin A21G, lowers body weight versus insulin lispro in type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4639, doi. 10.1111/dom.15827

By:

Andersen, Grit;
Eloy, Rosy;
Heise, Tim;
Gaudier, Martin;
Mégret, Claire;
Seroussi, Cyril;
Chan, You‐Ping;
Soula, Olivier;
Riddle, Matthew;
DeVries, J. Hans

Publication type:

Article

Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1941, doi. 10.1111/dom.15510

By:

Hövelmann, Ulrike;
Engberg, Susanne;
Heise, Tim;
Kristensen, Niels Rode;
Nørgreen, Lea;
Zijlstra, Eric;
Ribel‐Madsen, Rasmus

Publication type:

Article

Pharmacokinetic and pharmacodynamic bioequivalence of Gan & Lee insulin analogues aspart (rapilin®), lispro (prandilin®) and glargine (basalin®) with EU‐ und US‐sourced reference insulins.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3817, doi. 10.1111/dom.15281

By:

Chen, Wei;
Lu, Jia;
Plum‐Mörschel, Leona;
Andersen, Grit;
Zijlstra, Eric;
He, Anshun;
Xie, Tian;
Li, Longling;
Hao, Chunyue;
Gan, Zhongru;
Heise, Tim

Publication type:

Article

Cover Image.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1, doi. 10.1111/dom.15067

By:

Andersen, Grit;
Eloy, Rosy;
Famulla, Susanne;
Heise, Tim;
Meiffren, Grégory;
Seroussi, Cyril;
Gaudier, Martin;
Mégret, Claire;
Chan, You‐Ping;
Soula, Olivier;
Riddle, Matthew

Publication type:

Article

A co‐formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1241, doi. 10.1111/dom.14972

By:

Andersen, Grit;
Eloy, Rosy;
Famulla, Susanne;
Heise, Tim;
Meiffren, Grégory;
Seroussi, Cyril;
Gaudier, Martin;
Mégret, Claire;
Chan, You‐Ping;
Soula, Olivier;
Riddle, Matthew

Publication type:

Article

Oral insulin: A history of ambition, failure and data torturing.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 940, doi. 10.1111/dom.14984

By:

Heise, Tim;
Plum‐Mörschel, Leona;
Zijlstra, Eric

Publication type:

Article

Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once‐weekly dosing for the treatment of patients with diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1080, doi. 10.1111/dom.14956

By:

Heise, Tim;
Chien, Jenny;
Beals, John M.;
Benson, Charles;
Klein, Oliver;
Moyers, Julie S.;
Haupt, Axel;
Pratt, Edward John

Publication type:

Article

Safety, tolerability, pharmacodynamics and pharmacokinetics following once‐daily doses of BI 187004, an inhibitor of 11 beta‐hydroxysteroid dehydrogenase‐1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 832, doi. 10.1111/dom.14932

By:

Bianzano, Susanna;
Nordaby, Matias;
Plum‐Mörschel, Leona;
Peil, Barbara;
Heise, Tim

Publication type:

Article

What is the value of faster acting prandial insulin? Focus on ultra rapid lispro.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1689, doi. 10.1111/dom.14773

By:

Heise, Tim;
Piras de Oliveira, Carolina;
Juneja, Rattan;
Ribeiro, Anderson;
Chigutsa, Farai;
Blevins, Thomas

Publication type:

Article

Cover Image, Volume 23, Issue 3.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 4, p. 1, doi. 10.1111/dom.14378

By:

Andersen, Grit;
Famulla, Susanne;
Heise, Tim;
Ranson, Aymeric;
Seroussi, Cyril;
Eloy, Rosy;
Gaudier, Martin;
Charvet, Richard;
Chan, You‐Ping;
Soula, Olivier;
DeVries, J. Hans

Publication type:

Article

ADO09, a co‐formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 4, p. 961, doi. 10.1111/dom.14302

By:

Andersen, Grit;
Meiffren, Grégory;
Famulla, Susanne;
Heise, Tim;
Ranson, Aymeric;
Seroussi, Cyril;
Eloy, Rosy;
Gaudier, Martin;
Charvet, Richard;
Chan, You‐Ping;
Soula, Olivier;
DeVries, J. Hans

Publication type:

Article

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5).

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 619, doi. 10.1111/dom.14257

By:

Ólafsdóttir, Arndís F.;
Bolinder, Jan;
Heise, Tim;
Polonsky, William;
Ekelund, Magnus;
Wijkman, Magnus;
Pivodic, Aldina;
Ahlén, Elsa;
Schwarcz, Erik;
Nyström, Thomas;
Hellman, Jarl;
Hirsch, Irl B.;
Lind, Marcus

Publication type:

Article

Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1789, doi. 10.1111/dom.14094

By:

Heise, Tim;
Linnebjerg, Helle;
Coutant, David;
LaBell, Elizabeth;
Zijlstra, Eric;
Kapitza, Christoph;
Bue‐Valleskey, Juliana;
Zhang, Qianyi;
Dellva, Mary Anne;
Leohr, Jennifer

Publication type:

Article

Pharmacokinetic and pharmacodynamic bioequivalence of proposed biosimilar MYL‐1501D with US and European insulin glargine formulations in patients with type 1 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 521, doi. 10.1111/dom.13919

By:

Heise, Tim;
Donnelly, Charles;
Barve, Abhijit;
Aubonnet, Patrick

Publication type:

Article

Better glycaemic control with BioChaperone glargine lispro co‐formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1570, doi. 10.1111/dom.13685

By:

Meiffren, Grégory;
Alluis, Bertrand;
Mégret, Claire;
Gaudier, Martin;
Soula, Olivier;
Herbrand, Theresa;
Klein, Oliver;
DeVries, J. Hans;
Heise, Tim;
Anastassiadis, Ernestos;
Plum‐Mörschel, Leona

Publication type:

Article

BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 1066, doi. 10.1111/dom.13621

By:

Heise, Tim;
Meiffren, Grégory;
Alluis, Bertrand;
Seroussi, Cyril;
Ranson, Aymeric;
Arrubla, Jorge;
Correia, José;
Gaudier, Martin;
Soula, Olivier;
Soula, Rémi;
DeVries, J. Hans;
Klein, Oliver;
Bode, Bruce

Publication type:

Article

Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 601, doi. 10.1111/dom.13562

By:

Hövelmann, Ulrike;
Olsen, Minna Brændholt;
Mouritzen, Ulrik;
Lamers, Daniela;
Kronshage, Birgit;
Heise, Tim

Publication type:

Article

Environmental effects of ambient temperature and relative humidity on insulin pharmacodynamics in adults with type 1 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 569, doi. 10.1111/dom.13555

By:

Al‐Qaissi, Ahmed;
Papageorgiou, Maria;
Javed, Zeeshan;
Heise, Tim;
Rigby, Alan S.;
Garrett, Andrew T.;
Hepburn, David;
Kilpatrick, Eric S.;
Atkin, Stephen L.;
Sathyapalan, Thozhukat

Publication type:

Article

Ultra‐rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14‐day crossover treatment study in people with type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 11, p. 2627, doi. 10.1111/dom.13442

By:

Andersen, Grit;
Meiffren, Grégory;
Lamers, Daniela;
DeVries, J. Hans;
Ranson, Aymeric;
Seroussi, Cyril;
Alluis, Bertrand;
Gaudier, Martin;
Soula, Olivier;
Heise, Tim

Publication type:

Article

Variability of insulin degludec and glargine 300 U/mL: A matter of methodology or just marketing?

Published in:

2018

By:

Heise, Tim;
Heckermann, Sascha;
Hans DeVries, J.

Publication type:

Letter to the Editor

Injecting without pressing a button: An exploratory study of a shield‐triggered injection mechanism.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1140, doi. 10.1111/dom.13203

By:

Zijlstra, Eric;
Coester, Hans‐Veit;
Heise, Tim;
Plum‐Mörschel, Leona;
Rasmussen, Ole;
Rikte, Tord;
Pedersen, Line Kynemund;
Qvist, Marianne;
Sparre, Thomas

Publication type:

Article

Insulin degludec: Lower day-to-day and within-day variability in pharmacodynamic response compared with insulin glargine 300 U/ mL in type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 1032, doi. 10.1111/dom.12938

By:

Heise, Tim;
Nørskov, Marianne;
Nosek, Leszek;
Kaplan, Kadriye;
Famulla, Susanne;
Haahr, Hanne L.

Publication type:

Article

Novel hepato-preferential basal insulin peglispro ( BIL) does not differentially affect insulin sensitivity compared with insulin glargine in patients with type 1 and type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 4, p. 482, doi. 10.1111/dom.12834

By:

Porksen, Niels;
Linnebjerg, Helle;
Garhyan, Parag;
Lam, Eric C. Q.;
Knadler, Mary P.;
Jacober, Scott J.;
Hoevelmann, Ulrike;
Plum‐Moerschel, Leona;
Watkins, Elaine;
Gastaldelli, Amalia;
Heise, Tim

Publication type:

Article

Effects on α- and β-cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic study.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 4, p. 489, doi. 10.1111/dom.12838

By:

Forst, Thomas;
Falk, Alexander;
Andersen, Grit;
Fischer, Annelie;
Weber, Matthias M.;
Voswinkel, Stephan;
Heise, Tim;
Kapitza, Christoph;
Plum‐Mörschel, Leona

Publication type:

Article

Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 2, p. 208, doi. 10.1111/dom.12803

By:

Heise, Tim;
Zijlstra, Eric;
Nosek, Leszek;
Rikte, Tord;
Haahr, Hanne

Publication type:

Article

Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 33, doi. 10.1111/dom.12759

By:

Linnebjerg, Helle;
Lam, Eric Chen Quin;
Zhang, Xin;
Seger, Mary E.;
Coutant, David;
Chua, Laiyi;
Kapitza, Christoph;
Heise, Tim

Publication type:

Article

Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 3, doi. 10.1111/dom.12782

By:

Heise, Tim;
Mathieu, Chantal

Publication type:

Article

Euglycaemic glucose clamp: what it can and cannot do, and how to do it.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 10, p. 962, doi. 10.1111/dom.12703

By:

Heise, Tim;
Zijlstra, Eric;
Nosek, Leszek;
Heckermann, Sascha;
Plum‐Mörschel, Leona;
Forst, Thomas

Publication type:

Article

A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage.

Published in:

Frontiers in Aging, 2022, p. 1, doi. 10.3389/fragi.2022.852569

By:

Lizzo, Giulia;
Migliavacca, Eugenia;
Lamers, Daniela;
Frézal, Adrien;
Corthesy, John;
Vinyes-Parès, Gerard;
Bosco, Nabil;
Karagounis, Leonidas G.;
Hövelmann, Ulrike;
Heise, Tim;
von Eynatten, Maximilian;
Gut, Philipp

Publication type:

Article

Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes.

Published in:

Diabetes Care, 2023, v. 46, n. 5, p. 998, doi. 10.2337/dc22-1710

By:

Heise, Tim;
DeVries, J. Hans;
Urva, Shweta;
Li, Jing;
Pratt, Edward J.;
Thomas, Melissa K.;
Mather, Kieren J.;
Karanikas, Chrisanthi A.;
Dunn, Julia;
Haupt, Axel;
Milicevic, Zvonko;
Coskun, Tamer

Publication type:

Article

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI.

Published in:

2021

By:

Lind, Marcus;
Ólafsdóttir, Arndís F.;
Hirsch, Irl B.;
Bolinder, Jan;
Dahlqvist, Sofia;
Pivodic, Aldina;
Hellman, Jarl;
Wijkman, Magnus;
Schwarcz, Erik;
Albrektsson, Henrik;
Heise, Tim;
Polonsky, William

Publication type:

journal article

Differences in Physiological Responses to Cardiopulmonary Exercise Testing in Adults With and Without Type 1 Diabetes: A Pooled Analysis.

Published in:

2021

By:

Eckstein, Max L.;
Farinha, Juliano Boufleur;
McCarthy, Olivia;
West, Daniel J.;
Yardley, Jane E.;
Bally, Lia;
Zueger, Thomas;
Stettler, Christoph;
Boff, Winston;
Reischak-Oliveira, Alvaro;
Riddell, Michael C.;
Zaharieva, Dessi P.;
Pieber, Thomas R.;
Müller, Alexander;
Birnbaumer, Philipp;
Aziz, Faisal;
Brugnara, Laura;
Haahr, Hanne;
Zijlstra, Eric;
Heise, Tim

Publication type:

journal article

The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4).

Published in:

2020

By:

Seyed Ahmadi, Shilan;
Westman, Klara;
Pivodic, Aldina;
Ólafsdóttir, Arndís F.;
Dahlqvist, Sofia;
Hirsch, Irl B.;
Hellman, Jarl;
Ekelund, Magnus;
Heise, Tim;
Polonsky, William;
Wijkman, Magnus;
Schwarcz, Erik;
Lind, Marcus

Publication type:

journal article

Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog.

Published in:

2018

By:

Hövelmann, Ulrike;
Bysted, Britta Væver;
Mouritzen, Ulrik;
Macchi, Francesca;
Lamers, Daniela;
Kronshage, Birgit;
Møller, Daniél Vega;
Heise, Tim

Publication type:

journal article

Insulin Injection Into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control.

Published in:

2016

By:

Famulla, Susanne;
Hövelmann, Ulrike;
Fischer, Annelie;
Coester, Hans-Veit;
Hermanski, Lidia;
Kaltheuner, Matthias;
Kaltheuner, Lars;
Heinemann, Lutz;
Heise, Tim;
Hirsch, Laurence

Publication type:

journal article

New Insulin Glargine 300 Units⋅mL-1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 Units⋅mL-1.

Published in:

Diabetes Care, 2015, v. 38, n. 4, p. 637, doi. 10.2337/dc14-0006

By:

Becker, Reinhard H. A.;
Dahmen, Raphael;
Bergmann, Karin;
Lehmann, Anne;
Jax, Thomas;
Heise, Tim

Publication type:

Article

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.

Published in:

Journal of Clinical Investigation, 2014, v. 124, n. 2, p. 499, doi. 10.1172/JCI72227

By:

Ferrannini, Ele;
Muscelli, Elza;
Frascerra, Silvia;
Baldi, Simona;
Mari, Andrea;
Heise, Tim;
Broedl, Uli C.;
Woerle, Hans-Juergen

Publication type:

Article

Association of HbA1c with VO 2max in Individuals with Type 1 Diabetes: A Systematic Review and Meta-Analysis.

Published in:

Metabolites (2218-1989), 2022, v. 12, n. 11, p. 1017, doi. 10.3390/metabo12111017

By:

Eckstein, Max L.;
Aberer, Felix;
Dobler, Florian J. R.;
Aziz, Faisal;
Heise, Tim;
Sourij, Harald;
Moser, Othmar

Publication type:

Article

A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus.

Published in:

Drugs & Aging, 2017, v. 34, n. 1, p. 29, doi. 10.1007/s40266-016-0418-6

By:

Heise, Tim;
Hövelmann, Ulrike;
Zijlstra, Eric;
Stender-Petersen, Kirstine;
Jacobsen, Jacob;
Haahr, Hanne

Publication type:

Article

Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabetes.

Published in:

Diabetes Care, 2012, v. 35, n. 12, p. 2626, doi. 10.2337/dc12-0270

By:

BOLLI, GEREMIA B.;
HAHN, ANNKE D.;
SCHMIDT, RONALD;
EISENBLAETTER, TANJA;
DAHMEN, RAPHAEL;
HEISE, TIM;
BECKER, REINHARD H. A.

Publication type:

Article

A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naive people with type 2 diabetes: a randomized, controlled trial.

Published in:

2011

By:

Heise T;
Tack CJ;
Cuddihy R;
Davidson J;
Gouet D;
Liebl A;
Romero E;
Mersebach H;
Dykiel P;
Jorde R;
Heise, Tim;
Tack, Cees J;
Cuddihy, Robert;
Davidson, Jaime;
Gouet, Didier;
Liebl, Andreas;
Romero, Enrique;
Mersebach, Henriette;
Dykiel, Patrik;
Jorde, Rolf

Publication type:

journal article

A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naïve People With Type 2 Diabetes.

Published in:

Diabetes Care, 2011, v. 34, n. 3, p. 669, doi. 10.2337/dc10-1905

By:

HEISE, TIM;
TACK, CRES J.;
CUDDIHY, ROBERT;
DAVIDSON, JAIME;
GOUET, DIDIER;
LIEBL, ANDREAS;
ROMERO, ENRIQUE;
MERSEBACH, HENRIETTE;
DYKIEL, PATRIK;
JORDE, ROLF

Publication type:

Article

Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes.

Published in:

Diabetes Care, 2010, v. 33, n. 6, p. 1288, doi. 10.2337/dc09-1807

By:

Kapitza, Christoph;
Zijlstra, Eric;
Heinemann, Lutz;
Castelli, M. Cristina;
Riley, Gary;
Heise, Tim

Publication type:

Article